Sign in with your email address username.


[Department of Error] Department of Error

Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to fulfil the promise of personalised medicine. Lancet 2015; 385: 2118–19—In this Viewpoint (May 23), the Declarations of interest section should have stated that David Agus co-founded Navigenics in 2006, but has had no financial interest in the company since February, 2010. This correction has been made to the online Viewpoint as of June 26, 2015.